Efficient synthesis of [11C]befloxatone, a selective radioligand for the in vivo imaging of MAO-A density using PET

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 46, Issue 9, 2003, Pages 783-792

  Dolle F ^a   Bramoulle Y ^a   Hinnen, F ^a   Demphel, S ^a   George, P ^b   Bottlaender, M ^a  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

^b SANOFI   (France)

Author keywords

Befloxatone; Carbon 11; MAO; Monoamine oxidase; PET; Positron emission tomography

Indexed keywords

CARBON;

BEFLOXATONE; CARBON-11; EFFICIENT SYNTHESIS; IN-VIVO IMAGING; MAO; METHOXYMETHYL; MONOAMINE OXIDASE; MONOAMINE OXIDASE A; RADIOLIGANDS; RADIOSYNTHESIS;

POSITRON EMISSION TOMOGRAPHY;

BEFLOXATONE; CARBON 11; MONOAMINE OXIDASE INHIBITOR; RADIOLIGAND; TRACER;

ARTICLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; KINETICS; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; SYNTHESIS;

GYMNOMYZA SAMOENSIS;

EID: 0042365047     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlcr.718     Document Type: Article

References (36)

1. Singer TP, Ramsay RA, FASEB J 1995; 9: 605-610.
2. O'Carroll A-M, Fowler JC, Phillips JP, Tobbia I, Tipton KF. Naunyn-Schmiedeberg's Arch Pharmacol 1983; 322: 198-202.
3. Fowler CJ, Tipton KF. J Pharm Pharmacol 1984; 36: 111-115.
4. Johnston JP. Biochem Pharmacol 1968; 17: 1286-1297.
5. Knoll J, Maygar K, Adv Biochem Psychopharmacol 1972; 5: 393-406.
6. Youdim MBH, Finberg JPM. Monoamine oxidase inhibitor antidepressants. In Psychopharmacology 2. Part 1. Preclinical Psychopharmacology, Grahame-Smith DG (ed.), Elsevier: Amsterdam, 1985; 35-70.
7. Stronlin-Benedetti M, Dostert P. Trends Pharmacol Sci 1985; 6: 246-251.
8. Youdim MBH, Finberg JPM, Tipton KF. Monoamine oxidases. In Catecholamines I. Handbook of Experimental Psychopharmacology, vol 10, Trendelenburg U, Weiner N (eds), Springer: Berlin, 1988; 119-192.
9. Fowler CJ, Oreland L, Callingham BA. Pharm Pharmacol 1981; 33: 341-399.
10. Strolin-Benedetti M, Dostert P, Biochem Pharmacol 1989; 38, 555-561.
11. Brunner HG, Nelen M, Breakefield XO, Ropers HH, Van Oost BA. Science 1993; 262: 578.
12. MacGregor RR, Halldin C, Fowler JS, Wolf AP, Arnett CD, Langstrom B and Alexoff D, Biochem Pharmacol 1985; 34: 3207-3210.
13. Arnett CD, Fowler JS, MacGregor RR, Schlyer DJ, Wolf AP, Langstrom B and Halldin C, J Neurochem 1987; 49: 522-527.
14. Fowler JS, MacGregor RR, Wolf AP, Arnett CD, Dewey SL, Schlyer D, Christman D, Logan J, Smith M, Sachs H, Aquilonius M, Bjurling P, Halldin C, Hartvig P, Leenders KL, Lundqvist H, Oreland L, Stalnacke CG and Langström B, Science 1987; 235: 481-485.
15. MacGregor RR, Fowler JS, Wolf AP. Label Compds Radiopharm 1988; 25: 1-9.
16. Fowler JS, Wang GJ, Logan J, Xie S, Volkow ND, MacGregor RR, Schlyer DJ, Pappas N, Alexoff DL, Patlak C and Wolf AP, J Nucl Med 1995; 36: 1255-1262.
17. Fowler JS, Volkow ND, Wang G-J, Pappas N, Logan J, MacGregor RR, Alexoff D, Shea C, Wolf AP, Warner D, Zezulkova I and Cilento R, Nature 1996; 379: 733-736.
18. Fowler JS, Volkow ND, Wang G-J, Logan J, Pappas N, Shea C and MacGregor RR, Neurobiol Aging 1997; 18: 431-435.
19. Fowler JS, Volkow ND, Wang GJ, Pappas N, Shea C, MacGregor RR, Logan J, Adv Pharmacol 1998; 42: 304-307.
20. Fowler JS, Ding YS, Logan J, MacGregor RR, Shea C, Garza V, Gimi R, Vilkow ND, Wang GJ, Schlyer D, Ferrieri RA, Gatley SJ, Alexoff DL, Carter P, King P and Pappas N, Nucl Med Biol 2001; 28: 779-785.
21. Fowler JS, MacGregor RR, Wolf AP, Arnett CD, Dewey SL, Schlyer D, Christman DR, Logan J, Smith M, Sachs H, Aquilonius SM, Bjurling P, Halldin C, Hartvig P, Leenders KL, Lundquist H, Oreland L, Stalnacke CG and Langström B, Science 1987; 235: 481-485.
22. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Shea C, Alexoff DL, MacGregor RR, Schlyer D, Zezulkova I and Wolf AP, Proc Natl Acad Sci USA 1996; 93: 14065-14069.
23. Logan J, Fowler JS, Ding YS, Franceschi D, Wang GJ, Volkov ND, Felder C and Alexoff D, J. Cereb Blood Flow Metab 2002; 22: 1367-1376.
24. Fowler JS, Logan J, Ding YS, Franceschi D, Wang GJ, Volkow ND, Pappas N, Schlyer D, Gatley JS, Alexoff D, Felder C, Biegon A and Zhu W, J Neurochem 2001; 79: 1039-1046.
25. MacGregor RR, Halldin C, Fowler JS, Wolf AP, Arnett CD, Langström B and Alexoff D, Biochem Pharmacol 1985; 34: 3207-3210.
26. Curet O, Damoiseau G, Labaune JP, Rovei V, Jarreau FX. J Neural Transm 1994; 41: 349-355.
27. Rovei V, Caille D, Curet O, Ego D, Jarreau FX. J Neural Transm 1994; 41: 339-347.
28. Curet O, Damoiseau G, Aubin N, Sontag N, Rovei V, Jarreau FX. J Pharmacol Exp Ther 1996; 77: 253-264.
29. Caille D, Bergis OE, Fankhauser C, Gardes A, Adam R, Charieras T, Grosset A, Rovei V and Jarreau FX, J Pharmacol Exp Ther 1996; 277: 265-277.
30. Haddjeri N, De Montigny C, Curet O, Blier P. Eur J Pharmacol 1998; 343: 179-192.
31. Wouters J, Moureau F, Evrard G, Koenig JJ, Jegham S, George P and Durant F, Bioorg Med Chem 1999; 7: 1683-1693.
32. Bottlaender M, Dollé F, Guenther I, Roumenov D, Fuseau C, Bramoullé Y, Curet O, Jegham S, Pinquier JL, George P and Valette H, J Pharmacol Exp Ther 2003; 305: 467-473.
33. Dollé F, Valette H, Bramoullé Y, Guenther I, Fuseau C, Coulon C, Lartizien C, Jegham S, Curet O, Pinqier JL, Gegore P and Bottlaender M, Bioorg Med Chem Lett 2003; 13: 1771-1775.
34. Delforge J, Pappata S, Millet P, Samson B, Bendriem B, Jobert A, Crouzel C and Syrota A, J Cereb Blood Flow Metab 1995; 15: 284-300.
35. Landais P, Crouzel C. Appl Radiat Isot 1987; 38: 297-300.
36. Link JM, Krohn KA. J Label Compds Radiopharm 1997; 40: 306-308.